Cervical cancer: Nearly 8,000 deaths recorded yearly, experts raise alarm

Cervical cancer has reached an alarming level in Nigeria, experts have warned.

According to health stakeholders, Cervical cancer cases surged in the country, claiming 7,968 lives annually.

The disease, according to reports, is Nigeria’s 2nd leading cancer among women, causing 16% of cases.

Cervical cancer

This type of cancer occurs in the lower part of the uterus (cervix) in women.

Human papilloma virus (HPV) is often the major cause.

Experts recommend vaccination and regular screening for prevention.

Experts shared their insights at a vaccine awareness and uptake program in Lagos, hosted by Pathfinder in collaboration with the Medical Women Association of Nigeria (MWAN), Nigeria Cancer Society (NCS), and the Lagos State Primary Health Care Development Board

Dr. Adeniji Adebayo of the Lagos State Primary Healthcare Board revealed that Nigeria has one of the world’s highest rates of cervical cancer incidence rates globally

Adebayo said: “It not only affects the physical health of women but also takes a toll on families and communities.

“Human Papillomavirus, HPV, is primarily transmitted through direct skin-to-skin contact, usually through sexual activity.

“The virus infects the genital areas of both men and women and can also affect the mouth and throat.

“The most common mode of transmission is through sexual intercourse, including vaginal, anal, and oral sex.

“The virus can be passed from one person to another even if there are no visible signs of infection or symptoms,” he added.

Dr. Funmi Ige, President of MWAN, actively promotes women’s health by urging parents to vaccinate their young girls (9-14 years) against cervical cancer.

“Nobody should peddle rumours that people would be killed through vaccination because it is false,” Ige said.

For Diaspora Digital Media Updates click on Whatsapp, or Telegram. For eyewitness accounts/ reports/ articles, write to: citizenreports@diasporadigitalmedia.com. Follow us on X (Fomerly Twitter) or Facebook